FDA Inspection
Recipharm Pharmaservices Private LimitedRecipharm Pharmaservices Private Limited – FDA Inspection, Dec 14, 2017
Record Details
This FDA Inspection record concerns Recipharm Pharmaservices Private Limited, with an inspection on December 14, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- December 14, 2017
- Product Type
- Human Drugs
View Company Profile
ID · 0f338ab7-111a-4a18-a919-9a24011077df
Inspection Facts
- Inspection number
- 1037690
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Recipharm Pharmaservices Private Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 7, 2018 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| May 11, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Recipharm Pharmaservices Private Limited
- FDA Inspection 1232473 - 2024-03-22
- FDA Inspection 1119410 - 2020-02-13
- FDA Inspection 1079034 - 2019-02-01
- FDA Inspection 1075220 - 2018-12-07
- FDA Inspection 1053644 - 2018-05-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.